Enanta Pharmaceuticals
ENTA
ENTA
176 hedge funds and large institutions have $1.08B invested in Enanta Pharmaceuticals in 2019 Q3 according to their latest regulatory filings, with 13 funds opening new positions, 81 increasing their positions, 54 reducing their positions, and 31 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more ownership
Funds ownership: →
more funds holding in top 10
Funds holding in top 10: →
less funds holding
Funds holding: →
28% less call options, than puts
Call options by funds: $5.22M | Put options by funds: $7.2M
28% less capital invested
Capital invested by funds: $1.49B → $1.08B (-$414M)
58% less first-time investments, than exits
New positions opened: 13 | Existing positions closed: 31
Holders
176
Holding in Top 10
3
Calls
$5.22M
Puts
$7.2M
Top Buyers
| 1 | +$18.9M | |
| 2 | +$12M | |
| 3 | +$11.5M | |
| 4 |
Renaissance Technologies
New York
|
+$6.77M |
| 5 |
Goldman Sachs
New York
|
+$5.81M |
Top Sellers
| 1 | -$28.3M | |
| 2 | -$10.5M | |
| 3 | -$6.56M | |
| 4 |
Janus Henderson Group
London,
United Kingdom
|
-$4.78M |
| 5 |
Fidelity Investments
Boston,
Massachusetts
|
-$4.42M |